NCT00026754Completed
Eligibility Screening for the NIH Intramural Research Program Clinical Protocols
Source: ClinicalTrials.gov · Last updated 18 Apr 2025
Brief summary (registry, in English)
The purpose of this protocol is to provide patients with adequate informed consent to understand that screening tests with minimal health risk will be performed to evaluate their eligibility for a research study. The protocol makes it clear that patients initial visit to the intramural clinical program may include screening studies that are not medically necessary for disease management, but are done purely for research purposes. Patients with a known or suspected diagnosis of cancer, HIV infection, skin disorder or immunodeficiency who are being considered for enrollment in a National Cancer Institute intramural clinical research protocol will participate in this consent protocol. It informs patients of screening tests and procedures involving minimal risk that are done for research purposes only, including blood tests, electrocardiogram, standard X-rays (e.g., chest X-ray), bone films, computed tomography (CT), magnetic resonance imaging (MRI), and nuclear medicine studies. It explains that other eligibility screens that are more invasive and involve greater risk, such as a biopsy, will require separate consent. ...
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 19522 (actual)
- First submitted
- 14 Nov 2001
- Start date
- 14 Jan 2004
- Primary completion date
- 29 Nov 2024
- Lead sponsor
- National Cancer Institute (NCI)
- Diseases
- Prostate cancer, HIV, Melanoma, Lung cancer, Childhood cancers, Sarcoma
- NCT number
- NCT00026754
What you commit to
- Study type: Observational
- Participants enrolled: 19522
- From 14 Jan 2004 to the primary completion date, 29 Nov 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- None
Criteria the registry did not label
- INCLUSION CRITERIA:
- Patients and healthy volunteers who are being evaluated for protocols within the NIH Intramural Research Program (IRP). Note: Participants must be \> 1 month of age.
- All patients or their parent/guardians or Legally Authorized Representative (LAR) must sign a document of informed consent indicating their understanding of the research nature and the risks of the procedures that will be performed to assess eligibility for research protocols. NOTE: It is expected that healthy adult volunteers have the capacity to consent (i.e., a LAR may not be used).
Age in the registry: 1 month to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| National Institutes of Health Clinical Center Coordinator of this site? Confirm its status | Bethesda | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.